Page last updated: 2024-10-26

dimethadione and Idiopathic Parkinson Disease

dimethadione has been researched along with Idiopathic Parkinson Disease in 1 studies

Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.

Research Excerpts

ExcerptRelevanceReference
" Following oral dosing in rats for 7 days, salbutamol and triflusal, but not dimethadione or trazodone, significantly elevated FGF20 levels in the nigrostriatal tract."1.51Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats. ( Doherty, P; Duty, S; Fletcher, EJR; Jamieson, AD; Williams, G, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fletcher, EJR1
Jamieson, AD1
Williams, G1
Doherty, P1
Duty, S1

Other Studies

1 other study available for dimethadione and Idiopathic Parkinson Disease

ArticleYear
Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.
    Scientific reports, 2019, 06-06, Volume: 9, Issue:1

    Topics: Albuterol; Animals; Brain; Computer Simulation; Corpus Striatum; Dimethadione; Dopaminergic Neurons;

2019